Lung Cancer Profiling Panel - Liquid biopsy
استعرض التفاصيل الكاملة لهذا الفحص التشخيصيمعلومات الفحص
الاسم: Lung Cancer Profiling Panel - Liquid biopsy
الكود: G5641-AN
نوع العينة: Liquid biopsy
المدة المتوقعة (TAT): 16 يوم
التحضيرات والملاحظات
16ml Liquid biopsy (cfDNA) is a next generation sequencing (NGS) based test designed to empower personalized treatment decisions in patients with lung cancer microsatellite instability (MSI) . The detection is based on DNA, and utlizes unique molecular barcode (UMI) for digital error correction with limit of detection equal to 0.1% allele frequency .